CTOs on the Move

Uncommon Cacao

www.uncommoncacao.com

 
Uncommon Cacao is a cocoa supplier that provides premium wholesale cacao beans for chocolate makers. They embrace transparent trade to source quality cacao by measuring and delivering transparent pricing data for every transaction along their supply ch...
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Butts Foods

Butts Foods have been industry leaders in protein distribution since 1935.

Gotham Greens

Gotham Greens is a global pioneer in the field of urban agriculture and a leading regional producer of hyper-local, premium-quality vegetables and herbs.

Nexira

Nexira Number one in the worldwide acacia gum market, and a leader in natural ingredients for the food, nutrition, and health industries

Legacy Foodservice Alliance

A distributor marketing and purchasing group offering a new vision of customer service to the foodservice industry.

Neptune Technologies and Bioressources

Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.